Company Update (NYSE:PFE): Pfizer Celebrates a Year of Achievements in 2015 Annual Review

[Business Wire] – Pfizer Inc. released today its 2015 integrated annual review, an in-depth look into the company’s financial, social and environmental performance. 2015 was marked by breakthrough scientific research, collaborations and partnerships. Read more on this. Pfizer Inc. (PFE) , currently valued at $182.37B, opened at $29.88. Today, shares have traded between $29.30 and $29.92 per share with a trailing 52-week range being $28.25 to $36.46. PFE shares are currently priced at 13.32x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 2.70x earnings multiple. And for dividend hunters, the company pays shareholders $1.20 per share annually in dividends, yielding 3.93%. Consensus earnings for the current quarter by the 15 sell-side analysts covering the stock is an estimate of $0.55 per share, which would be $0.04 better than the year-ago quarter and a $0.03 sequential decrease. What we find to be interesting is that the full-year EPS estimate of $2.29 is a $0.09 better when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $11.92 Billion. If reported, that would be a 9.76% increase over the year-ago quarter. In terms of ratings, Sun Trust Rbsn Humphrey upgraded PFE from Reduce to Neutral (Nov 25, 2015). Previously, Morgan Stanley upgraded PFE from Equal-Weight to Overweight. Investors should keep in mind is that the average price target is $38.81, which is 29.89% above where the stock opened this morning. See more in (NYSE:PFE) Similar Articles: Company Update: Pfizer Inc (NYSE:PFE) – Pfizer Announces Collaboration with GSK on Next-Generation Design of Portable, Continuous, Miniature and Modular (PCMM) Oral Solid Dose Development and Manufacturing Units Company Update: Pfizer Inc (NYSE:PFE) – Corrected-Merck KGaA says avelumab alliance with Pfizer on track Market Update (NYSE:PFE): Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference